The DOI matches its Crossref record; 178 of the 181 references it cites were found in a registry or an index.
Bile salt biotransformations by human intestinal bacteria
Open accessAbstract
Secondary bile acids, produced solely by intestinal bacteria, can accumulate to high levels in the enterohepatic circulation of some individuals and may contribute to the pathogenesis of colon cancer, gallstones, and other gastrointestinal (GI) diseases. Bile salt hydrolysis and hydroxy group dehydrogenation reactions are carried out by a broad spectrum of intestinal anaerobic bacteria, whereas bile acid 7-dehydroxylation appears restricted to a limited number of intestinal anaerobes representing a small fraction of the total colonic flora. Microbial enzymes modifying bile salts differ between species with respect to pH optima, enzyme kinetics, substrate specificity, cellular location, and possibly physiological function. Crystallization, site-directed mutagenesis, and comparisons of protein secondary structure have provided insight into the mechanisms of several bile acid-biotransforming enzymatic reactions. Molecular cloning of genes encoding bile salt-modifying enzymes has facilitated the understanding of the genetic organization of these pathways and is a means of developing probes for the detection of bile salt-modifying bacteria. The potential exists for altering the bile acid pool by targeting key enzymes in the 7alpha/beta-dehydroxylation pathway through the development of pharmaceuticals or sequestering bile acids biologically in probiotic bacteria, which may result in their effective removal from the host after excretion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary conjugated BAs synthesized in the liver, such as the tauro- and glycoconjugates of cholic acid (TCA, GCA), are deconjugated by BSHs to generate cholic acid (CA)”
From Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut (2023) · cites this paper as [11]
In the citing paper
“This vanguard reaction acts as a ‘gatekeeper’ for subsequent BA transformations that turn primary BAs into secondary BAs”
From Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut (2023) · cites this paper as [11]
In the citing paper
“There is an intensive bidirectional interaction between BAs and intestinal microbiota.51”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [51]
In the citing paper
“Primary bile acids are converted to secondary bile acids by the local microbiota, partly in the small intestine and predominantly in the colon. This involves multiple steps and typically begins with the initial deconjugation of glycine or taurine, followed by dehydroxylation (Ridlon et al., 2006).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Ridlon et al., 2006
In the citing paper
“Bile acid activity of commensal bacteria is involved in a complex interplay with host hepatic enzymes, and together they promote digestion and absorption of dietary lipids.42”
From The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids (2015) · cites this paper as [42]
Citations
Cites
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Prokaryotes: The unseen majority
Whitman, W. B., Coleman, D. C., & Wiebe, W. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6578 · Cited by 4,871 · cited 1×
“Bacterial density in the human colon is among the highest found in nature, approaching 10(12) bacteria/ gram wet weight feces (2, 3).”
BackgroundMICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436
The interaction between bacteria and bile
Begley, M., Gahan, C. G. M., & Hill, C. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.09.003 · Cited by 1,776
Comparative Genomics of Listeria Species
Glaser, P., Frangeul, L., Buchrieser, C., Rusniok, C., Amend, A., Baquero, F., Berche, P., Blöcker, H., Brandt, P., Chakraborty, T., et al. (2001) · Science · doi:10.1126/science.1063447 · Cited by 1,505
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
The Continuing Importance of Bile Acids in Liver and Intestinal Disease
Hofmann, A. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2647 · Cited by 972
Wyatt, J. S., Delpy, D. T., Cope, M., Wray, S., & Reynolds, E. O. R. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90467-8 · Cited by 875
Narisawa, T., Magadia, N. E., Weisburger, J. H., & Wynder, E. L. (1974) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/53.4.1093 · Cited by 704
Hepatology. A Textbook of Liver Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-259_2 · Cited by 624
Cited by
Sorted by citations
Items 601–700 of 1,014
Bile Acids, Their Receptors, and the Gut Microbiota
Poland, J. C., & Flynn, C. R. (2021) · Physiology · doi:10.1152/physiol.00028.2020 · Cited by 93
Singh, R. K. (2016) · SOJ Microbiology & Infectious Diseases · doi:10.15226/sojmid/4/1/00148 · Cited by 89
Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy
Mancini, A., Campagna, F., Amodio, P., & Tuohy, K. M. (2018) · Food & Function · doi:10.1039/c7fo01528c · Cited by 89
Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
Jia, W. P., Rajani, C., Xu, H., & Zheng, X. (2020) · Protein & Cell · doi:10.1007/s13238-020-00748-0 · Cited by 91
Jia, W., Rajani, C., Kaddurah‐Daouk, R., & Li, H. (2020) · Medicinal Research Reviews · doi:10.1002/med.21653 · Cited by 88
Liu, H., Tian, R., Wang, H., Feng, S., Li, H., Xiao, Y., Luan, X., Zhang, Z., Shi, N., Niu, H., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02539-x · Cited by 88
Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation
Li, C., Liang, Y., & Qiao, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.863407 · Cited by 88
The bridge of the gut–joint axis: Gut microbial metabolites in rheumatoid arthritis
Xu, X., Wang, M., Wang, Z., Chen, Q., Chen, X., Xu, Y., Dai, M., Wu, B., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1007610 · Cited by 87
Xu, M., Lan, R., Qiao, L., Lin, X., Hu, D., Zhang, S., Yang, H. J., Zhou, J., Ren, Z., Li, X., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02517-22 · Cited by 89
Gnewuch, C., Liebisch, G., Langmann, T., Dieplinger, B., Mueller, T., Haltmayer, M., Dieplinger, H., Zahn, A., Stremmel, W., Rogler, G., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.3134 · Cited by 88
Humanized microbiota mice as a model of recurrent Clostridium difficile disease
Collins, J., Auchtung, J. M., Schaefer, L., Eaton, K. A., & Britton, R. A. (2015) · Microbiome · doi:10.1186/s40168-015-0097-2 · Cited by 88
Bile acid oxidation byEggerthella lentastrains C592 and DSM 2243T
Harris, S. C., Devendran, S., Méndez–García, C., Mythen, S. M., Wright, C. L., Fields, C. J., Hernandez, A. G., Cann, I., Hylemon, P. B., & Ridlon, J. M. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1458180 · Cited by 87
Self-citationNaumann, S., Schweiggert‐Weisz, U., Eglmeier, J., Haller, D., & Eisner, P. (2019) · Nutrients · doi:10.3390/nu11061424 · Cited by 87
Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease
Li, T., & Chiang, J. Y. L. (2020) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2019.09.03 · Cited by 87
Mechanisms of Parenteral Nutrition–Associated Liver and Gut Injury
Madnawat, H., Welu, A., Gilbert, E., Taylor, D. B., Jain, S., Manithody, C., Blomenkamp, K., & Jain, A. K. (2019) · Nutrition in Clinical Practice · doi:10.1002/ncp.10461 · Cited by 87
The Role of the Gut Microbiome in Energy Balance With a Focus on the Gut-Adipose Tissue Axis
Han, X., & Kang, S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00297 · Cited by 88
Jarocki, P., Podleśny, M., Glibowski, P., & Targoński, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114379 · Cited by 87
Impacts of the Human Gut Microbiome on Therapeutics
Vázquez‐Baeza, Y., Callewaert, C., Debelius, J. W., Hyde, E. R., Marotz, C. A., Morton, J. T., Swafford, A. D.-E., Vrbanac, A. F., Dorrestein, P. C., & Knight, R. D. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-042017-031849 · Cited by 87
Microbiota-Derived Metabolic Factors Reduce Campylobacteriosis in Mice
Sun, X., Winglee, K., Gharaibeh, R. Z., Gauthier, J., He, Z., Tripathi, P., Avram, D., Bruner, S. D., Fodor, A. A., & Jobin, C. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.042 · Cited by 87
Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases
Hyun, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179139 · Cited by 87
Aguirre, M., Eck, A., Koenen, M. E., Savelkoul, P. H. M., Budding, A. E., & Venema, K. (2015) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2015.07.019 · Cited by 86
Sun, P., Jin, M., Ding, L., Lu, Y., Ma, H., Yuan, Y., & Zhou, Q. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.02.018 · Cited by 86
Barathikannan, K., Chelliah, R., Rubab, M., Daliri, E. B., Elahi, F., Kim, D.-H., Agastian, P., Oh, S.-Y., & Oh, D. H. (2019) · Microorganisms · doi:10.3390/microorganisms7100456 · Cited by 85
Melatonin Alleviates Neuroinflammation and Metabolic Disorder in DSS-Induced Depression Rats
Lv, W., Liu, C., Yu, L., Zhou, J., Li, Y., Xiong, Y., Guo, A., Chao, L., Qu, Q., Guang-wei, W., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1241894 · Cited by 85
Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease
Markandey, M., Bajaj, A., Ilott, N. E., Kedia, S., Travis, S. P. L., Powrie, F. M., & Ahuja, V. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1990827 · Cited by 85
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 85
Zhao, H., Zhou, X., Song, Y., Zhao, W., Sun, Z., Zhu, J., & Yu, Y. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01683-0 · Cited by 85
The interrelationship between bile acid and vitamin A homeostasis
Saeed, A., Hoekstra, M., Hoeke, M. O., Heegsma, J., & Faber, K. N. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.01.007 · Cited by 85
Alteration of gut microbiota in association with cholesterol gallstone formation in mice
Wang, Q., Jiao, L. R., He, C., Sun, H., Cai, Q., Han, T., & Hu, H. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0629-2 · Cited by 85
Bai, J., Zhu, Y. G., & Dong, Y. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.12.050 · Cited by 85
Gut microbiota, fatty liver disease, and hepatocellular carcinoma
Chu, H., Williams, B., & Schnabl, B. (2018) · Liver Research · doi:10.1016/j.livres.2017.11.005 · Cited by 84
Obesity and its associated disease: a role for microbiota?
Tehrani, A. B., Nezami, B. G., Gewirtz, A. T., & Srinivasan, S. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01895.x · Cited by 84
The Mechanism of Enterohepatic Circulation in the Formation of Gallstone Disease
Cai, J.-S., & Chen, J. (2014) · The Journal of Membrane Biology · doi:10.1007/s00232-014-9715-3 · Cited by 84
Patterns and Scales in Gastrointestinal Microbial Ecology
Camp, J. G., Kanther, M., Semova, I., & Rawls, J. F. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.075 · Cited by 85
Colonization Resistance of the Gut Microbiota against Clostridium difficile
Pérez‐Cobas, A. E., Moyá, A., Gosalbes, M. J., & Latorre, A. (2015) · Antibiotics · doi:10.3390/antibiotics4030337 · Cited by 85
A review of Clostridioides [Clostridium] difficile occurrence through the food chain
Candel-Pérez, C., Ros, G., & Martínez‐Graciá, C. (2018) · Food Microbiology · doi:10.1016/j.fm.2018.08.012 · Cited by 84
Theriot, C. M., & Young, V. B. (2013) · Gut Microbes · doi:10.4161/gmic.27131 · Cited by 83
Comparative Review of the Responses of Listeria monocytogenes and Escherichia coli to Low pH Stress
Arcari, T., Feger, M.-L., Guerreiro, D. N., Wu, J., & O'Byrne, C. P. (2020) · Genes · doi:10.3390/genes11111330 · Cited by 83
Characterization of Enantiomeric Bile Acid-induced Apoptosis in Colon Cancer Cell Lines
Katona, B. W., Anant, S., Covey, D. F., & Stenson, W. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805804200 · Cited by 83
Zhang, L., Bahl, M. I., Roager, H. M., Fonvig, C. E., Hellgren, L. I., Frandsen, H. L., Pedersen, O. B., Holm, J., Hansen, T. F., & Licht, T. R. (2016) · The ISME Journal · doi:10.1038/ismej.2016.151 · Cited by 83
Trefflich, I., Marschall, H., di Giuseppe, R., Ståhlman, M., Michalsen, A., Lampen, A., Abraham, K., & Weikert, C. (2019) · Nutrients · doi:10.3390/nu12010047 · Cited by 81
Chains of evidence from correlations to causal molecules in microbiome-linked diseases
Chaudhari, S. N., McCurry, M. D., & Devlin, A. S. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00861-z · Cited by 82
Molecular interactions between the intestinal microbiota and the host
Hertli, S., & Zimmermann, P. (2022) · Molecular Microbiology · doi:10.1111/mmi.14905 · Cited by 82
Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis
Pan, Y., Zhang, H., Li, M., He, T., Guo, S., Zhu, L., Tan, J., & Wang, B. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2356284 · Cited by 84
Ecology and characteristics of methanogenic archaea in animals and humans
Saengkerdsub, S., & Ricke, S. C. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.763220 · Cited by 82
He, X., Ji, G., Jia, W. P., & Li, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030300 · Cited by 82
Gu, X., Zhou, J., Zhou, Y., Wang, H., Si, N., Ren, W., Zhao, W., Fan, X., Gao, W., Wei, X., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00779-7 · Cited by 81
Thandapilly, S. J., Ndou, S. P., Wang, Y., Nyachoti, C. M., & Ames, N. P. (2018) · Food & Function · doi:10.1039/c8fo00157j · Cited by 81
Olivera, E. R., & Luengo, J. M. (2019) · Genes · doi:10.3390/genes10070512 · Cited by 81
Hua, Y., Jia, Y., Zhang, X., Yuan, Z., Ji, P., Hu, J., & Wei, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111320 · Cited by 81
Ferrandi, E. E., Bertolesi, G. M., Polentini, F., Negri, A. L., Riva, S., & Monti, D. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3798-x · Cited by 81
Ogura, M., Nishida, S., Ishizawa, M., Sakurai, K., Shimizu, M., Matsuo, S., Amano, S., Uno, S., & Makishima, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145987 · Cited by 81
Metabolomics of fecal samples: A practical consideration
Matysik, S., Roy, C. I. L., Liebisch, G., & Claus, S. P. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.05.011 · Cited by 81
Alterations in gut microbial function following liver transplant
Bajaj, J. S., Kakiyama, G., Cox, I. J., Nittono, H., Takei, H., White, M. B., Fagan, A., Gavis, E. A., Heuman, D. M., Gilles, H., et al. (2018) · Liver Transplantation · doi:10.1002/lt.25046 · Cited by 81
Self-citationGenomic Comparison of Lactobacillus helveticus Strains Highlights Probiotic Potential
Fontana, A., Falasconi, I., Molinari, P., Treu, L., Basile, A., Vezzi, A., Campanaro, S., & Morelli, L. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01380 · Cited by 81
Proton Pump Inhibitors and the Risk of Colorectal Cancer
van Soest, E. M., van Rossum, L. G. M., Dieleman, J. P., van Oijen, M. G. H., Siersema, P. D., Sturkenboom, M. C. J. M., & Kuipers, E. J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01665.x · Cited by 80
Role of bile acids in the regulation of the metabolic pathways
Taoka, H., Yokoyama, Y., Morimoto, K., Kitamura, N., Tanigaki, T., Takashina, Y., Tsubota, K., & Watanabe, M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i13.260 · Cited by 80
The role of bacteria in the inflammatory bowel disease development: a narrative review
Azimi, T., Nasiri, M. J., Chirani, A. S., Pouriran, R., & Dabiri, H. (2018) · Apmis · doi:10.1111/apm.12814 · Cited by 80
PBDEs Altered Gut Microbiome and Bile Acid Homeostasis in Male C57BL/6 Mice
Li, C. Y., Dempsey, J. L., Wang, D., Lee, S., Weigel, K. M., Fei, Q., Bhatt, D. K., Prasad, B., Raftery, D., Gu, H., et al. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081547 · Cited by 80
Regulation of body weight: Lessons learned from bariatric surgery
Albaugh, V. L., He, Y., Münzberg, H., Morrison, C. D., Yu, S., & Berthoud, H. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101517 · Cited by 80
Increasing dietary oat fibre decreases the permeability of intestinal mucus
Mackie, A. R., Rigby, N. M., Harvey, P., & Bajka, B. H. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.08.018 · Cited by 80
Shi, Y., Kellingray, L., Zhai, Q., Gall, G. L., Narbad, A., Zhao, J., Zhang, H., & Chen, W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01948 · Cited by 80
Role of Bile Acids in Bariatric Surgery
Wang, W., Cheng, Z., Wang, Y., Dai, Y., Zhang, X., & Hu, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00374 · Cited by 80
Xiao, Y., Zhou, K., Lu, Y., Yan, W., Cai, W., & Wang, Y. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0181-3 · Cited by 79
The PPAR–microbiota–metabolic organ trilogy to fine‐tune physiology
Oh, H. Y. P., Visvalingam, V., & Wahli, W. (2019) · The FASEB Journal · doi:10.1096/fj.201802681rr · Cited by 79
Molecular Regulation of Bile Acid Homeostasis
Choudhuri, S., & Klaassen, C. D. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000643 · Cited by 79
Role of the microbiota–gut–heart axis between bile acids and cardiovascular disease
Zhang, Z., Lv, T., Wang, X., Wu, M., Zhang, R., Yang, X., Fu, Y., & Liu, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116567 · Cited by 79
Zheng, M., Wang, R., Li, C., & Xu, J. (2015) · Process Biochemistry · doi:10.1016/j.procbio.2014.12.026 · Cited by 79
Specific bile acids inhibit hepatic fatty acid uptake in mice
Nie, B., Park, H. M., Kazantzis, M., Lin, M., Henkin, A. H., Ng, S. M., Song, S., Chen, Y., Tran, H., Lai, R., et al. (2012) · Hepatology · doi:10.1002/hep.25797 · Cited by 79
Bongers, G., Pacer, M. E., Geraldino, T. H., Chen, L., He, Z., Hashimoto, D., Furtado, G. C., Ochando, J., Kelley, K. A., Clemente, J. C., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131587 · Cited by 79
Enright, E. F., Joyce, S. A., Gahan, C. G. M., & Griffin, B. T. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01155 · Cited by 79
Connors, J., Dunn, K. A., Allott, J., Bandsma, R., Rashid, M., Otley, A. R., Bielawski, J. P., & Limbergen, J. V. (2019) · The ISME Journal · doi:10.1038/s41396-019-0560-3 · Cited by 78
Acharya, C., & Bajaj, J. S. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.056 · Cited by 79
Kang, Y., Cai, Y., & Yang, Y. X. (2021) · Liver Cancer · doi:10.1159/000521358 · Cited by 78
Neuroinflammation, Microbiota-Gut-Brain Axis, and Depression: The Vicious Circle
Reyes-Martínez, S., Segura-Real, L., Gómez-García, A. P., Tesoro-Cruz, E., Constantino-Jonapa, L. A., Amedei, A., & Aguirre‐García, M. M. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2203065 · Cited by 78
Detection technologies and metabolic profiling of bile acids: a comprehensive review
Liu, Y., Rong, Z., Xiang, D., Zhang, C., & Liu, D. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0774-9 · Cited by 78
Ma, C., Zhang, S., Lü, J., Zhang, C., Pang, X., & Lv, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092073 · Cited by 78
Dollerup, O. L., Trammell, S. A. J., Hartmann, B., Holst, J. J., Christensen, B., Møller, N., Gillum, M. P., Treebak, J. T., & Jessen, N. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01081 · Cited by 77
Gut-microbiota derived bioactive metabolites and their functions in host physiology
Debnath, N., Kumar, R., Kumar, A., Mehta, P. K., & Yadav, A. K. (2021) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2021.1989847 · Cited by 77
Choucair, I., Nemet, I., Li, L., Cole, M. A., Skye, S. M., Kirsop, J. D., Fischbach, M. A., Gogonea, V., Brown, J. M., Tang, W. H. W., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000311 · Cited by 77
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Zhang, Y., Li, Z.-J., Gou, H.-Z., Song, X., & Zhang, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.945368 · Cited by 77
Fuchs, C. D., Paumgartner, G., Mlitz, V., Kunczer, V., Halilbasic, E., Leditznig, N., Wahlström, A., Ståhlman, M., Thüringer, A., Kashofer, K., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314553 · Cited by 76
Fecal and urinary NMR-based metabolomics unveil an aging signature in mice
Calvani, R., Brasili, E., Praticò, G., Capuani, G., Tomassini, A., Marini, F., Sciubba, F., Finamore, A., Roselli, M., Marzetti, E., et al. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.10.010 · Cited by 76
The Role of Canalicular ABC Transporters in Cholestasis
Cuperus, F. J. C., Claudel, T., Gautherot, J., Halilbasic, E., & Trauner, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056358 · Cited by 76
Zeng, H., Larson, K., Cheng, W., Bukowski, M. R., Safratowich, B. D., Liu, Z., & Hakkak, R. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108336 · Cited by 76
Aboushanab, S. A., Khedr, S. M., Гетте, И. Ф., Danilova, I. G., Кольберг, Н. А., Ravishankar, G. A., Rao, A. R., & Kovaleva, E. G. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1946006 · Cited by 76
Zou, B., Li, J., Ma, R., Cheng, X.-Y., Ma, R.-Y., Zhou, T.-Y., Wu, Z., Yao, Y., & Li, J. (2023) · Aging and Disease · doi:10.14336/ad.2022.1127 · Cited by 76
Kiriyama, Y., & Nochi, H. (2023) · Microorganisms · doi:10.3390/microorganisms11112730 · Cited by 77
Wahlstrom, A. M., Brumbaugh, A. R., Sjöland, W., Olsson, L. M., Wu, H., Henricsson, M., Lundqvist, A., Makki, K., Hazen, S. L., Bergström, G. M. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48543-3 · Cited by 76
Ohtani, N. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0457-1 · Cited by 76
Hudson, L. E., Anderson, S. E., Corbett, A. H., & Lamb, T. J. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00049-16 · Cited by 76
Allain, T., Chaouch, S., Thomas, M., Vallée, I., Buret, A. G., Langella, P., Grellier, P., Polack, B., Bermúdez‐Humarán, L. G., & Florent, I. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02707 · Cited by 76
Developments in bile salt based therapies: A critical overview
Donkers, J. M., Abbing, R. L. P. R., & van de Graaf, S. F. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.12.018 · Cited by 76
Amelioration of TMAO through probiotics and its potential role in atherosclerosis
Din, A. U., Hassan, A., Zhu, Y. S., Yin, T., Gregersen, H. N., & Wang, G. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10142-4 · Cited by 76
Urinary intermediates of tryptophan as indicators of the gut microbial metabolism
Pavlová, T., Vidová, V., Vašků, J. B., Janků, P., Almáši, M., Klánová, J., & Spáčil, Z. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.08.022 · Cited by 75
Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection
Kachrimanidou, M., & Tsintarakis, E. (2020) · Microorganisms · doi:10.3390/microorganisms8020200 · Cited by 75
Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti‐tumor immunity
Sipe, L. M., Chaib, M., Pingili, A. K., Pierre, J. F., & Makowski, L. (2020) · Immunological Reviews · doi:10.1111/imr.12856 · Cited by 75
Bhattacharjee, A., Burr, A. B. P., Overacre-Delgoffe, A. E., Tometich, J. T., Yang, D., Huckestein, B. R., Linehan, J. L., Spencer, S. P., Hall, J. A., Harrison, O. J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.07.005 · Cited by 75
Immunomodulatory functions of FXR
Fiorucci, S., Zampella, A., Ricci, P., Distrutti, E., & Biagioli, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111650 · Cited by 75
Heinsen, F., Knecht, H., Neulinger, S. C., Schmitz, R. A., Knecht, C., Kühbacher, T., Rosenstiel, P. C., Schreiber, S., Friedrichs, A. K., & Ott, S. J. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1062959 · Cited by 75
Metadata
- Authors
- Ridlon, J. M., Kang, D.-J., & Hylemon, P. B.
- Affiliations
- Virginia Commonwealth University (US)
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 47
- Issue
- 2
- Pages
- 241-259
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2071273298
- Cited by
- 2,829
- References
- 181
- Citations by year
- 2026: 202 · 2025: 220 · 2024: 211 · 2023: 245 · 2022: 263 · 2021: 252 · 2020: 238 · 2019: 200 · 2018: 191 · 2017: 161 · 2016: 130 · 2015: 119 · 2014: 87 · 2013: 91 · 2012: 51
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK038030, P01 DK 38030)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- secondary bile acids, enterohepatic circulation, enzyme kinetics, enzyme structure, gene cloning, probiotics, bile acid sequestration, colon cancer, gallstones
- MeSH terms
- Amidohydrolases, Amino Acid Sequence, Bacteria, Bile Acids and Salts, Biotransformation, Cholic Acids, Colonic Neoplasms, Humans, Hydrogen Sulfide, Hydroxysteroid Dehydrogenases, Intestinal Mucosa, Intestines, Models, Molecular, Molecular Sequence Data, Taurine, Molecular Structure, Sequence Homology, Amino Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
